Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

INSP vs AETH: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

INSP Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 7–3 Matrix Metrics)

INSP Overall Winner 6-Pillar Tally: INSP 6 – 0 AETH Matrix Metrics: INSP 7 – 3 AETH

As of Nov 20, 2026, Inspire Medical Systems, Inc. (INSP) is the stronger overall head-to-head candidate over Bitwise Trendwise Ether and Treasuries Rotation Strategy ETF (AETH) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). INSP carries a Unified Composite Score of 52.5/100 (HOLD) at $55.10 (36.9x Forward P/E, 4.5% operating margin), whereas AETH carries 56.5/100 (HOLD) at $37.54 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While AETH currently prints a higher short-term Unified Composite Score (56.5/100 HOLD vs. INSP 52.5/100 HOLD), INSP captures the overall institutional head-to-head verdict (7–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (4.5% vs. N/A operating margin) and revenue trajectory (-7.9% vs. N/A YoY).
  • Technical & Structure Timing Caution: INSP is currently in a Breakdown options structure phase (RSI 27.4); meanwhile AETH trades in a Markup technical trend (SURGE options phase, RSI 54.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About INSP vs AETH
INSP NYSE Head-to-Head Winner
Inspire Medical Systems, Inc.
Surgical & Medical Instruments & Apparatus
$55.10
-2.1% 1D
Market Cap $1.6B
TTM Revenue $881M
Forward P/E 36.9x
Beta / 30D Vol 0.74β · 46% Vol
Unified Composite Score
52.5 / 100 HOLD
Tech 25.0 Fund 49.0 Flow 69.0 Mom 59.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 27
RSI-14: 27.4 · SMA20: $63.86 · SMA50: $68.05
AETH NYSE Arca
Bitwise Trendwise Ether and Treasuries Rotation Strategy ETF
Institutional Equity
$37.54
-0.09% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.96β · 29% Vol
Unified Composite Score
56.5 / 100 HOLD
Tech 48.0 Fund 50.0 Flow 54.0 Mom 60.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (10.5% over 20 days), RSI 54
RSI-14: 54.2 · SMA20: $38.06 · SMA50: $34.83

6-Pillar Scorecard Institutional Category Breakdown (INSP 6 – 0 AETH)

Columns: Metric · INSP · AETH
1. Valuation Multiples INSP
Forward P/E 36.9x N/M
Trailing P/E 16.8x N/M
PEG Ratio N/M N/M
EV / Revenue 1.7x N/M
2. Growth & Scale INSP
Revenue Growth (YoY) -7.9% N/A
Earnings Growth (YoY) +308.4% N/A
TTM Revenue (USD) $881M N/A
Market Cap $1.6B N/A
3. Profitability & Quality INSP
Gross Margin 86.2% N/A
Operating Margin 4.5% N/A
Net Profit Margin 11.4% N/A
Return on Equity (ROE) 13.5% N/A
4. Balance Sheet & Cash Flow INSP
Cash Generation (TTM) $98M N/A
Cash Flow Margin 11.1% N/A
Net Cash / Leverage $162M Net Cash N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning INSP
Options Structure Phase BREAKDOWN SURGE
Current IV / %ile 53.2% (7th %ile) 9.5% (1st %ile)
Put/Call OI Skew 69.97x (Put-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Neutral DISTRIBUTION · Markup
6. R&D & Supply-Chain Moat INSP
OpEx & R&D Intensity 81.7% of Rev ($720M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Devices Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: INSP (7) vs AETH (3)
Institutional Metric INSP AETH Criterion Row Edge
Market Capitalization
Scale
$1.6B N/A Larger Scale INSP
Trailing P/E Ratio
Valuation
16.8x N/M Lower Multiple INSP
Forward P/E Ratio
Valuation
36.9x N/M Lower Multiple INSP
Revenue Growth (YoY)
Growth
-7.9% N/A Higher Growth INSP
Operating Margin (TTM)
Profitability
4.5% N/A Higher Margin INSP
Net Profit Margin
Profitability
11.4% N/A Higher Margin INSP
Return on Equity (ROE)
Capital Efficiency
13.5% N/A Higher ROE INSP
52-Week Range Position
Momentum
15% ($39–$147) 47% ($28–$48) Stronger Trend AETH
Beta / 30D Volatility
Risk Regime
0.74β · 46% Vol 0.96β · 29% Vol Lower Realized Risk AETH
Unified Institutional Score
Composite Signal
52.5 / 100 (HOLD) 56.5 / 100 (HOLD) Higher Composite AETH
Trailing 12M Revenue (USD)
Operating Scale
$881M N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
86.2% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 1.7x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$98M ($162M Net Cash) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon INSP +13.61 pp
INSP: +13.74% · AETH: +0.13%
3M Horizon INSP +25.67 pp
INSP: +53.92% · AETH: +28.25%
6M Horizon INSP +25.73 pp
INSP: +35.65% · AETH: +9.92%
1Y Horizon AETH +11.44 pp
INSP: -16.13% · AETH: -4.69%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on INSP vs AETH. Trailing 12-month operating profitability (INSP 4.5% vs AETH N/A) and valuation multiples (INSP 36.9x vs AETH N/M Forward P/E) are benchmarked directly in Pillar 4 below.

INSP ADR TTM Benchmark FX-Normalized USD
TTM Revenue$881M
Gross Margin86.2%
Op. Margin4.5%
ROE / Fwd P/E13.5% · 36.9x
AETH ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
INSP BREAKDOWN
48d in phase · OBV DISTRIBUTION
Current IV 53.2%
IV Percentile 7th %ile
Put/Call OI Skew 69.97x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact INSP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
AETH SURGE
14d in phase · OBV DISTRIBUTION
Current IV 9.5%
IV Percentile 1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact AETH Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
INSP Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $1.6B market capitalization and 4.5% operating margin.
OpEx & R&D Reinvestment 81.7% of Rev ($720M)
90D Engineering Disclosures 0 Published
AETH Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ INSP vs AETH Key Questions & Quantitative Answers

As of Nov 20, 2026, Inspire Medical Systems, Inc. (INSP) is the stronger overall head-to-head candidate over Bitwise Trendwise Ether and Treasuries Rotation Strategy ETF (AETH) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). INSP carries a Unified Composite Score of 52.5/100 (HOLD) at $55.10 (36.9x Forward P/E, 4.5% operating margin), whereas AETH carries 56.5/100 (HOLD) at $37.54 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While AETH currently prints a higher short-term Unified Composite Score (56.5/100 HOLD vs. INSP 52.5/100 HOLD), INSP captures the overall institutional head-to-head verdict (7–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (4.5% vs. N/A operating margin) and revenue trajectory (-7.9% vs. N/A YoY). Technical & Structure Timing Caution: INSP is currently in a Breakdown options structure phase (RSI 27.4); meanwhile AETH trades in a Markup technical trend (SURGE options phase, RSI 54.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

INSP leads the Growth & Scale pillar: INSP posts -7.9% YoY revenue growth and +308.4% YoY earnings growth on $881M TTM revenue (86.2% gross margin, 4.5% operating margin), compared with AETH at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, INSP generates $881M in USD-normalized revenue versus N/A for AETH. In operating R&D and SG&A reinvestment, INSP deploys 81.7% of Rev ($720M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for AETH.

INSP screens cheaper on headline valuation multiples. INSP trades at 36.9x Forward P/E, 16.8x Trailing P/E, N/M PEG, and 1.7x EV/Revenue (11.1% FCF margin), whereas AETH trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against INSP (13.5% ROE) versus AETH (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, INSP carries 53.2% implied volatility (7th %ile, Compressed (<25th %ile)), a 69.97x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (0.74β · 46% Vol realized risk). By comparison, AETH carries 9.5% implied volatility (1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a SURGE options structure phase (0.96β · 29% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.